The following is excerpted from the question-and-answer section of the transcript.
(Questions from industry analysts are provided in full, but answers are omitted - download the transcript to see the full question-and-answer session)
Question: Madhukar Nahari - Nuvama Wealth Management Limited - Analyst
: First question on BALIC. So we see the growth has obviously come off significantly in this quarter and the mix has also changed. So what I wanted
to get a sense of is, and in the last few years, we've grown very rapidly. So I wanted to get a sense of what the growth trajectory in the near term
would shape up like? Or should we take this quarter as an aberration with sort of growth returning back to the 20%, 25% sort of level. How -- and
also then what product mix should we expect on this?
And then on the health side, I think there is a significant health -- insurance side a significant confusion in terms of what sort of production payouts
and the way commission payout should happen while I think GI Council idea, warrant commissions to be paid sort of on a yearly basis. And as
payments are meant that is not allowed. I think a large part of the distribution committee -- community is still sort of not in favor of this and -- so
how do you see this progressing? What approach have we taken? And some sort of color around that will be useful. Those would be my two
questions.
Tarun Chugh - Bajaj Finserv Ltd - Managing Director, Chief Executive Officer of Bajaj Allianz Life Insurance Company Ltd
So maybe I'll take the first one on BALIC and Tapan can step in for the health question. So we had indicated very clearly in the Investor Day that
while we've had a user trailblazing growth, in the last seven years. And particularly, if you look at the last three years, we've been the fastest growing
across the sector with a CAGR of 27%. This quarter, while the changes were happening, we purposely took a pause and relooked at our entire
product structures. With this change happening, it was obvious that the focus now is on profitability and profitable growth. And given the heft
that the company now already has in terms of the size, it could be meaningful numbers. This is something I have kind of indicated in the earlier
call as well.
In terms of how I see this going ahead, we did have a tough month in November, I think, purposely so because we had planned it like that after
September. And the sector also had a tough month in November, but I think we had a tougher one largely because of our agency business, which
is 150,000 agents getting retrained, getting reoriented to these kind of products. And of course, the fact that there was a founder value impact on
commissions.
The sector did on the agency side, particularly had an impact all through. Good news is that December, we are back to a slight mild growth. January
also, we are in -- broadly in sync with a lot of companies that we are -- we compare ourselves with. Agency though, is still going to take some more
time to settle in the new product mix and may take a few quarters before it starts coming back to its earlier growth trajectory. Bancassurance and
the PSF are largely getting back, but mostly in sync with the rest of the sector.
I hope that answers your question. I'm not going to give any clear numbers because as Sreeni made it clear, we do not make any forward-looking
statements.
REFINITIV STREETEVENTS | www.refinitiv.com | Contact Us
consent of Refinitiv. 'Refinitiv' and the Refinitiv logo are registered trademarks of Refinitiv and its affiliated companies.
JANUARY 31, 2025 / 4:30AM, BJFS.NS - Q3 2025 Bajaj Finserv Ltd Earnings Call
Question: Madhukar Nahari - Nuvama Wealth Management Limited - Analyst
: My second question is left.
Question: Madhukar Nahari - Nuvama Wealth Management Limited - Analyst
: So I wanted to get a sense of how distributor commission payouts are working in this new sort of scenario on my end. I believe a lot of the large
distributors still want upfront payment whereas IDI and GI Council are not in favor of it. And also, it would adversely affect our EOM ratios. So in
this context, how do you see the sort of industry moving?
And finally, also, given that OM ratios are very high, for a large part of the competition. What sort of action and competition also received notices
from IRDAI on this. So are we seeing any letdown in competitive intensity do we thought of foresee that? Any sort of early signs on the health side,
in particular?
REFINITIV STREETEVENTS | www.refinitiv.com | Contact Us
consent of Refinitiv. 'Refinitiv' and the Refinitiv logo are registered trademarks of Refinitiv and its affiliated companies.
JANUARY 31, 2025 / 4:30AM, BJFS.NS - Q3 2025 Bajaj Finserv Ltd Earnings Call
Tapan Singhel - Bajaj Finserv Ltd - Managing Director, Chief Executive Officer of Bajaj Allianz General Insurance Company Limited
Thank you for the question. So I think in your question lies the answer. The regulations have been very simplified, be it product regulations, be it
commission regulations. On the commission regulations stipulate EOM, expense of management. well-run companies who have EOM less than
30, which is what they have to be there.
I don't think they have any stress in terms of how they look at commission pay and the regulators does not stipulate how you pay commissions. It
stipulates that you should be under the EOM, not at the counties to plate how do you pay commission. So -- and your company, I think Bajaj
International company will look at. The EOM is well below 30. It's one of the well-run companies with an EOM well below 30.
So I think the question is more relevant to companies who are over EOM over 30. And that is essential, I think it's a good practice because at the
end of the day, what the policyholder gets also has a determination in terms of how your expense management plays out. And BALIC has been a
company for a long period of time, I think, from inception. We see has been one of the lowest company in terms of expense ratios, which should
be there.
So from that perspective, I don't think this has any impact on the company. And if I look at the industry, also, if you look at the overall numbers for
businesses, first and foremost, business, which is long term is not so significant in the overall business industry. Having said that, even there, I don't
see much fall in terms of the business falling or the distributor not selling for overall for industry also. So I would think for BALIC is is positive. And
for the industry also, I don't see any negative happening overall.
Question: Madhukar Nahari - Nuvama Wealth Management Limited - Analyst
: Sir, just on the health insurance question. My question was more with respect to sort of competitive intensity because a lot of these smaller players
are running at EUM levels, which are above sort of 30%, 35% for private and SAHIs. So in this context, paying upfront commission further increases
those ratios and loss ratios have also remained quite elevated on the health side. In that context, do we see some sort of corrective action in terms
of pricing or some competitive intensity let down -- any early signs of that or your thoughts on that, if you would expect anything like that. Plus
now senior citizens pricing is also capped so if -- as your sort of population ages, those cohorts age, you'll not be able to increase pricing beyond
sort of 60 years of age beyond 10%. So does that mean that pricing for the -- at an entry level also increases -- yes, on the health context, some sort
of understanding and clarity, I'd appreciate.
REFINITIV STREETEVENTS | www.refinitiv.com | Contact Us
consent of Refinitiv. 'Refinitiv' and the Refinitiv logo are registered trademarks of Refinitiv and its affiliated companies.
JANUARY 31, 2025 / 4:30AM, BJFS.NS - Q3 2025 Bajaj Finserv Ltd Earnings Call
Tapan Singhel - Bajaj Finserv Ltd - Managing Director, Chief Executive Officer of Bajaj Allianz General Insurance Company Limited
Yeah. So again, I think the question is a broad question for the industry. It's not specific to the company. I said for BAjaj Allianz General Insurance
Company, it is positive. Whatever you have said -- so this company operates well below the limit of 30%.
So it has like -- so obviously, this doesn't have an impact. For smaller companies, if they are over 35, they have to correct themselves at 30, they
have to clear light cost, and they have to deliver on that basis. The regulator is very clear on that. So obviously, they have to decide their strategy.
I can't speak for them.
In terms of civilian cap at 10% movement, it is that any increase in price would not be above 10%, which -- and if you look at the overall portfolio,
what percentage is senior citizen, what percentage is the normal increase in price that should happen. And it spreads across the entire cohort. And
then in that serials read the other part is exactly as industry should come forward with an agreement with hospitals in terms of standardized rates
and procedures. That will also have impact on the overall loss ratio. When you put all these things together, I don't think there's any apprehension
in terms of business.
I think it is good for the industry. And industry will come together to deliver on those parameters and bring it together. So I don't think it's something
which is so off the mark, which is going to have an impact in industry in terms of getting negative or not going the right ratio. All of what you see
in here is moving in the right direction. And 30% is a good limit to have, I think, in industries win and companies and above that, we'll have to
correct themselves and bring to that.
And the companies are operating in that for like I don't remember -- if I look at Bajaj International company, when we were at the early stage that
we would have had an which would have no cost these kind of limits. So it's how you run a company, how disciplined you are, which really matters.
So if you look at it from a skeptic perspective, it looks a bit odd. If you look at the overall picture, it's a very good thing for the industry. I don't think
there's any negative in this.
Question: Nischint Chawathe - Kotak Institution Equities - Analyst
: First of all, congrats, Sreeni, Ramandeep and best wishes to Ankur. I think, firstly, on the life side, you seem to be making significant changes or
probably overall in the entire business. So just curious, does it mean that we sort of have a low probably maybe a single digit or lower than industry
growth going forward in the next couple of quarters, probably the next year as well? I'm just trying to understand the intensity of the change that
you are making. And just on the surrender value guidelines, if you could quantify the change some of your peers have done that. I mean the impact.
Tarun Chugh - Bajaj Finserv Ltd - Managing Director, Chief Executive Officer of Bajaj Allianz Life Insurance Company Ltd
Yeah. No, that's a very good question. As far as the changes, yes, there are substantial that we've done. In terms of growth, there is often more for
us to take. I will not get on to which digits, single, double.
I don't think we're used to single-digit kind of growth, so don't worry about that. We will -- we've always maintained the stand that we'll be going
for after then the rest industry. And you'll see that happening. It's a temporary blip. And while I would say that the base effect for a few quarters
will play out.
But overall, for the year, as we see, growth will be quite visibly be back. So while the changes are substantial, and the rest of the sector has made
changes because we are under value only in track. For them, tried remains so the heavy lifter on profits. What we've done is we've changed the
REFINITIV STREETEVENTS | www.refinitiv.com | Contact Us
consent of Refinitiv. 'Refinitiv' and the Refinitiv logo are registered trademarks of Refinitiv and its affiliated companies.
JANUARY 31, 2025 / 4:30AM, BJFS.NS - Q3 2025 Bajaj Finserv Ltd Earnings Call
entire slew of products that we have, including ULIPs and also gotten the kind of riders we are adding significantly different to what BALIC has ever
done earlier in life. So that is an additional change, which will take time to set in.
But at the same time, whatever we get of that is only positive in terms of a trajectory on growth and profitable growth. So that's why we are a little
different from the rest of the sector. In terms of growth, it doesn't worry me much.
Question: Nischint Chawathe - Kotak Institution Equities - Analyst
: Got it. Just on BAGIC side, if I look at the long-term policies, what was the leading policy over here? And how is the inward commissioned for
long-term policies treated in the P&L?
Question: Nischint Chawathe - Kotak Institution Equities - Analyst
: So as we speak in terms of payouts have we deferred it or payouts remain as it is? And in terms of accounting, we have deferred both the sites.
Question: Nischint Chawathe - Kotak Institution Equities - Analyst
: Commission is also on the RI side being recognized up. And just one final one for Tapan, do you really see the non-life players coming together
with the hospitals. The way, let's say, IDA is asking the industry to do. I mean have you already seen any discussions on this in the IIB forums?
Tapan Singhel - Bajaj Finserv Ltd - Managing Director, Chief Executive Officer of Bajaj Allianz General Insurance Company Limited
Do you want me to answer the question is religious Chairman Generation.
Question: Nischint Chawathe - Kotak Institution Equities - Analyst
: Sure. But it's something that the industry will look forward to is what we see.
Tapan Singhel - Bajaj Finserv Ltd - Managing Director, Chief Executive Officer of Bajaj Allianz General Insurance Company Limited
It has to. You have to understand one thing. See, what was the problem. Look at the media, in spite of the industry is doing so much and in fact,
on the health portfolio and tall portfolio, overall industry is not making money. If we look at the media news, it is so negative at times.
But what is the problem for health insurance. It is the medical inflation and no regulation on hospitals coming into both. And that is what the
industry has been asking for that there's a three-pronged approach on health. One is the premium. Other is the tax that is GST.
And third is the outgo in terms of hospital charges is happening. Now hospital is not regulated. And GST the industry has been asking for reduction
in -- so the entire owner comes from industry than to take care of the whole portfolio and do the societal need of serving the society and putting
it together. Because others to the industry is demanding hopefully, they should, at some point of time, be considered.
Now if it is on the industry when the industry has no option but then to on its own method it generates, I think, to the hospital income of close to
INR1 lakh crore is what the industry is paying then the necessary industry comes together and at least there's some correction on that basis to be
able to deliver to society, the requirement of a good health cover for the season of India. So from that perspective, there's no other option but to
invest to come together and do this.
Question: Nidhesh Jain - Investec - Analyst
: The first question is on BALIC. So what is the rationale of reducing the share of ULIP as you've articulated the focus is on VNB growth and not on
VNB margins. So why are we reducing the share of ULIP in the product mix consciously?
Tarun Chugh - Bajaj Finserv Ltd - Managing Director, Chief Executive Officer of Bajaj Allianz Life Insurance Company Ltd
I think it's an obvious answer, ULIPs do have a lower VNB margin than tradition plans since we are reducing focus on ULIPs.
Question: Nidhesh Jain - Investec - Analyst
: Sure. Second question is on BAGIC. So if you look at BAGIC, we have done quite well on profitability vis-a-vis sector. We are very well capitalized,
and customer metrics are quite positive in terms of customer satisfaction, and we have a very strong distribution. But if you look at last four, five
years, despite a lot of these strength that we have, we have not been able to gain market share with the customer obsession that we have been
displaying and the customer metrics are issuing, ideally, such kind of business should see a rapid market share gain in the retail segment.
If you look at the float growth in last five years, the float has grown at 12% CAGR. So why is the market share trend and the float growth trend are
broadly in line with market and not significantly ahead of market?
Tapan Singhel - Bajaj Finserv Ltd - Managing Director, Chief Executive Officer of Bajaj Allianz General Insurance Company Limited
Okay. So I would like to look at it in a different way. First, if you look at BAGIC, it's in a top three company of Fed and organically grown. It has not
acquired any company than any merger acquisitions. In spite of that, it's organically grown.
And if you look at it on the top three company. With a significant millet has moved up organically in 23 years' time, brick by brick, been a top three
company, first point. Second point, at all points of time, the margin to the market in terms of combined ratio has always been over 15%. It is not a
15% profit percentage. It's a full 15% combined ratio perspective, which means that if the industry about 117, BAGIC has been close to 100.
REFINITIV STREETEVENTS | www.refinitiv.com | Contact Us
consent of Refinitiv. 'Refinitiv' and the Refinitiv logo are registered trademarks of Refinitiv and its affiliated companies.
JANUARY 31, 2025 / 4:30AM, BJFS.NS - Q3 2025 Bajaj Finserv Ltd Earnings Call
At times, industry is 120, BAGIC has been at 98, 99. So you gave me any business in the world, which for decades has beaten the combined ratio
by such huge margin and organically, these the top three position consistently moving up in terms of ranking in the market. So whatever Tarun
said has allowed BAGIC to reach this stage. Second point is we look at number of policy issued last year of all companies, you will see BAGIC issue
close to INR3.6 crore. If I'm not -- I don't remember the number -- complete number right time, but if Raman can correct the wrong.
And even the larger in terms of top line, India had issued INR2.67 crore or INR2.7 crore now. In terms of number of policies issued, BAGIC was the
highest number Indian market. So fundamentally, I think when you look at the positioning, the movement that is slowly move of the ranks and
where it stands over a long period of time consistently to the difference of profit to the market that it has made in terms of combined ratio, the
gap that is kept at all point of time, to the expense ratio, and you heard Raman mentioned by six industries over 30%. The kind of discrete is
maintained. I think it was fundamental things.
balancing of all three, not only buses pushing your weight and acquiring rapid in terms of position and moving on the market with is doing right
thing consistently over a long period of time. We deliver a good insurance company. And this is how it has to be. However if my numbers wrong
in terms of number of policies or they were close to right.
Question: Sanketh Godha - Avendus Spark - Analyst
: Yes, see, I have two questions on BAGIC. Both are related to third-party See, if I look at other players in Motor TP, the loss ratios are meaningfully
very low compared to what you guys are reporting. I just wanted to understand that is it to conservative reason, we are following. And therefore,
for likelihood of a release is very high going ahead? Or is it the product mix incrementally have changed in the favor of products where the claims
are a little higher than normal.
That is leading to the higher TP loss ratio? And second, the point I wanted to ask is that you seem to be growing very well in OD and probably
gaining market share also at least in the current year. But CP seems to be off complete market share gain point of view. So any specific reason for
the divergence in the growth trend? Or is it largely heroes playing out in OD as a strong growth on a low base.
That's my question on OD, moderate basically. And second on developments is on -- have you seen pricing improving in commercial lines already?
And if that is the case, then likely benefit of it coming in FY26 or calendar '25, how do you see it?
REFINITIV STREETEVENTS | www.refinitiv.com | Contact Us
consent of Refinitiv. 'Refinitiv' and the Refinitiv logo are registered trademarks of Refinitiv and its affiliated companies.
JANUARY 31, 2025 / 4:30AM, BJFS.NS - Q3 2025 Bajaj Finserv Ltd Earnings Call
Question: Sanketh Godha - Avendus Spark - Analyst
: Okay. No, it was on commercial lines fire segment.
Tapan Singhel - Bajaj Finserv Ltd - Managing Director, Chief Executive Officer of Bajaj Allianz General Insurance Company Limited
So let me answer the question. See, first and foremost, as a GI company. it's always better to be conservative than it will be reckless on reserving
to answer your question. And Bernie has always been conservative and never been reckless on reserving. And that's the point I made earlier also
that if you look at our release to reserving has always been there.
But that is our good GI company runs. On the part of increase of price for the commercial lines of business. So yes, we see the trend happening
there. And obviously, in my view, again, I've always mentioned this, is that the market forces to determine the right price for the right risk. That is
what it should always be there.
Right now, we see an increase in price happening, which is positive for the industry. And BALIC is being a large player in the commercial lender
businesses also, it will be good for whether intentions company if this sustains and this carries on, which is there. But the likelihood of subsidies is
there, it is -- as of now, it looks high, which should be the way move forward. Have I missed any question of yours or we have covered all?
Question: Sanketh Godha - Avendus Spark - Analyst
: My next question is on BALIC. The point is that basically, third quarter, as you highlighted, the growth was pretty muted compared to what we
have been delivering in the past. So just again to clarify, is it largely because you were trying to realign the channels with the new norms? That led
to the moderation of the growth or it was more conscious decision to slow down ULIP, which plays a major role. And if realignment of the channels
is the major reason, what -- how much more time you will take to see that realignment happens and the growth will come back to the company.
So that's one thing. And secondly, this is on tablet life business, it seems to be bottoming out because we did the same amount of business, what
we did in second quarter. So just wondering whether we can see a positive outlook in credit life incrementally going ahead.
Tarun Chugh - Bajaj Finserv Ltd - Managing Director, Chief Executive Officer of Bajaj Allianz Life Insurance Company Ltd
Yeah. So see, the changes that we've done this quarter have been substantially on the product and the product structures. The mix tweak has been
there. So you asked about ULIP. And are we steering away from ULIP?
No, we are not steering away from ULIP. Some customer segments, which will be very prone to ULIPs, and some distributors will be very prone to
ULIP as well. But on the whole, we are working more on the back end where we've treated our structures. To the earlier question that had come,
tweak the ability to take more expenses at the same time, structure them in such a way that customers get there a bit as well. This quarter has been
tough because we've had to do this on the fly all across, and we took a call that we've had a significant growth.
We've reached a certain level of size. Now it's time that we start looking at our overall VNB growth, and that is what you will start seeing in the
future. Whether specifically, we will grow in every channel significantly? I think our agency will take a little bit more time to settle in with agencies
far more dispersed. Our institutional business and the proprietary sales channels are more or less back now.
So we should start seeing, starting to clock industry-level growth while agency taking a little bit more time to come in as we reconfigure a lot many
things because distributors are usually trained to sell only a few bits of products. It may not be at agency very good at all. So that training is going
on. We're trying to engage with them more and trying to get them back on track. So maybe a quarter more may take before agency can start
coming in.
REFINITIV STREETEVENTS | www.refinitiv.com | Contact Us
consent of Refinitiv. 'Refinitiv' and the Refinitiv logo are registered trademarks of Refinitiv and its affiliated companies.
JANUARY 31, 2025 / 4:30AM, BJFS.NS - Q3 2025 Bajaj Finserv Ltd Earnings Call
So that's on the growth and the product shifts. As far as credit life is concerned, yes, you're right. And if you can foresee the future and you're saying
it's bottoming out, yes, then, of course, we'll be back. Everybody will be back in the sector. And as far as we are concerned, we have streamlined a
lot of our credit life across partners.
If you remember, a few quarters back, when we were discussing, our focus used to be more based on a couple of partners. And even the mix was
largely towards MFI. That, I'm happy to say, is quite well diversified now in terms of the partners we have, the number of partners we have. No set
of partners now contribute one or two partners do not contribute any significant part of our credit life portfolio. So that is kind of (technical difficulty).
Unidentified Participant
Thank you to all the participants for joining the call and a special thanks to the management team of Bajaj Finserv for giving us the opportunity to
host the call. Thank you, and good day, everyone.
|